Antibody De Novo Sequencing by LC-MS/MS and Bioinformatics

Rapid Novor Inc. is a fast-growing Canadian biotechnology company specializing in de novo sequencing of therapeutic antibodies and other proteins by LC-MS/MS, software processing, and bioinformatics. The amino acid sequence of therapeutic antibody plays a critical role in the rising biopharmaceutical industry for antibody drug discovery and development, regulatory filing and intellectual property protection.     

All we need is antibody sample (≥ 0.2mg, ≥95% purity). 

We will deliver: 

- Full sequence of heavy and light chains

- Full sequence coverage by LC-MS/MS

- Comprehensive report, and 

- Raw LC-MS/MS data

within 15 business days after receiving the sample.

Choose Rapid Novor Inc., your trusted partner, and expert to restore hybridoma cell line, assure antibody product and accelerate biosimilar/antibody drug development!

Rapid Novor Inc. is a fast-growing Canadian biotechnology company specializing in antibody de novo sequencing by LC-MS/MS, software processing, and bioinformatics. The amino acid sequence of therapeutic antibody plays a critical role in the rising biopharmaceutical industry for antibody drug discovery and development, regulatory filing and intellectual property protection.

All we need is antibody sample (≥ 0.2mg, ≥95% purity).

We will deliver:
- Full sequence of heavy and light chains
- Full sequence coverage by LC-MS/MS
- Comprehensive report, and
- Raw LC-MS/MS data

within 15 business days after receiving the sample.

Choose Rapid Novor Inc., your trusted partner, and expert to restore hybridoma cell line, assure antibody product and accelerate biosimilar/antibody drug development!